PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Jan-2022 TrakCel and Körber partner to provide orchestration within manufacturing of cell and gene therapies TrakCel
26-Jan-2022 CONFERENCE SERIES WIDENS INVESTOR ACCESS TO CUTTING-EDGE HEALTHCARE STOCKS Edison Group
26-Jan-2022 NICE EXPANDS GUIDANCE FOR LOKELMA®▼(sodium zirconium cyclosilicate) IN ADULT PATIENTS WITH PERSISTENT HYPERKALAEMIA AstraZeneca
26-Jan-2022 LoQus23 Therapeutics appoints Dr. Melanie Ivarsson, OBE, as Non-Executive Director LoQus23 Therapeutics
26-Jan-2022 OWEN MUMFORD ANNOUNCES ON MARKET RELEASE OF UNISAFE® 1mL SAFETY DEVICE FOR PRE-FILLED SYRINGES FEATURING INDUSTRY-FIRST SPRINGLESS MECHANISM Owen Mumford
26-Jan-2022 Verona Pharma Completes Enrollment in Phase 3 ENHANCE-2 Trial Evaluating Ensifentrine for Maintenance Treatment of COPD Verona Pharma
26-Jan-2022 Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA) Roche
26-Jan-2022 Defence Therapeutics Inc.: Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9 Defence Therapeutics Inc.
26-Jan-2022 Queen’s University Belfast enters collaboration and licensing agreement with Ipsen to progress FLIP inhibitor project which has been supported by Domainex Sciad Newswire
26-Jan-2022 Xlife Sciences raises CHF 5.0 million through capital increase Xlife Sciences AG
26-Jan-2022 Lonza Delivers Strong 2021 performance with 20% CER Sales Growth Lonza Group AG
25-Jan-2022 Abivax 2022 Financial Communication Calendar ABIVAX
25-Jan-2022 FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy PTC Therapeutics
25-Jan-2022 Biotage Launches TurboVap® 96 Dual Evaporator B3C newswire
25-Jan-2022 Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology Evotec SE
24-Jan-2022 MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report MorphoSys AG
24-Jan-2022 Original-Research: Defence Therapeutics Inc. (von GBC AG) Defence Therapeutics Inc.
24-Jan-2022 Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 2021 (+30%); further sales growth and EBITDA improvement planned for FY/2022 aap Implantate AG
24-Jan-2022 Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs RELIEF THERAPEUTICS Holding AG
24-Jan-2022 Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon 'Next-Gen' Colorectal Cancer Screening Test Epigenomics AG